BRNS vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 15, 2026

BRNS

53.9
AI Score
VS
BRNS Wins

CLYM

44.4
AI Score

Investment Advisor Scores

BRNS

54score
Recommendation
HOLD

CLYM

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BRNS CLYM Winner
Net Income -66.43M -27.22M CLYM
Operating Income -70.56M -30.57M CLYM
ROE -89.5% -11.4% CLYM
ROA -67.7% -11.1% CLYM
Total Assets 98.17M 246.29M CLYM
Cash 70.46M 44.11M BRNS
Current Ratio 7.77 31.45 CLYM
Free Cash Flow -48.02M -25.18M CLYM

Relative Price Performance (Last 90 Days)

BRNS 1M: -11.8% · 3M: -13.1% CLYM 1M: +29.8% · 3M: +44.1%

Current Technical Phase

BRNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.6 · Price: $0.59

CLYM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.7% over 20 days), RSI 74

RSI (14): 74.2 · Price: $16.33

Fundamentals Snapshot

Metric BRNS CLYM
Market Cap
Forward P/E -0.5 -15.5
Trailing P/E
Revenue (TTM)
Revenue Growth -1.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -1.05 -0.82
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BRNS is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.